Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider
Nykode Therapeutics ASA (NYKD) · publisert 10. oktober 2025 kl. 12:36 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass |
|---|---|---|---|---|---|---|---|
| Michael Engsig | – | Kjøp | 55 944 | 1,79 NOK | 10. oktober 2025 | NO0010714785 | XOSL - Oslo Stock Exchange |
Vedlegg
- Attachment 251010.pdf (application/pdf, originaldokument)
Meldingstekst
Oslo, Norway, October 10, 2025 - Primary insider Michael Engsig, Chief Executive Officer of Nykode Therapeutics ASA, has today acquired 55,944 shares in Nykode Therapeutics ASA at a price of NOK 1.79 per share. Following the transaction, Michael Engsig holds 71,794 shares in Nykode Therapeutics ASA.
Please see further details in the attached document.